My Account Log in

1 option

Innovation and the pharmaceutical industry : critical reflections on the virtues of profit / edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett.

Ebook Central Academic Complete Available online

View online
Format:
Book
Contributor:
Engelhardt, H. Tristram (Hugo Tristram), Jr., 1941-2018.
Garrett, Jeremy R.
Series:
Conflicts and trends.
Trends and conflicts
Language:
English
Subjects (All):
Pharmaceutical industry.
Drug development.
Medical innovations.
Medical policy--United States.
Medical policy.
Drugs--economics--United States.
Drugs.
Physical Description:
1 online resource (253 p.)
Place of Publication:
Salem, MA : M & M Scrivener Press, c2008.
Language Note:
English
Summary:
Innovation and the Pharmaceutical Industry: Critical Reflections on the Virtues of Profit examines the central role of profit in the development of pharmaceuticals, medical devices, and health care generally. Recent efforts to understand this role have often underestimated and even dismissed its importance, arguing for its replacement by other means and mechanisms. However, as the essays in this volume attest, it would be impossible to account adequately for the range of pharmaceuticals and medical devices that have become part of everyday medicine without recognizing that the depth and scope of innovations are tied not simply to altruism, a concern for the common good, or the pursuit of knowledge for its own sake, but crucially to the pursuit of private good and of individual profit. Balancing a concern for theory and practice, the analyses and evaluations provided in these essays touch directly on many of the most heated and important debates in pharmaceutical ethics, such as profit margins, corporate social responsibility, drug advertising, litigation, patents, and parallel trade. Reflecting critically on the problems and prospects of medical innovation, they invite a rethinking of the foundations of the bioethics and business ethics of the pharmaceutical and medical device industries by focusing on the long-term impact of policy decisions for human health and well-being.
Contents:
Pharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett
The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr
Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi
Pharmaceutical companies: psychopaths or scapegoats / Pepe Lee Chang
Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor
Pharmaceutical advertising and patient autonomy / Andrew I. Cohen
Does America have a second drug problem? / Richard A. Epstein
Global drug innovation in a world of financial finitude: retailing virtue to promote
Capital formation and profit / Michael A. Rie
Time, money, and the market for drugs / John C. Goodman
Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham
Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis.
Notes:
Description based upon print version of record.
Includes bibliographical references and index.
ISBN:
1-281-72653-2
9786611726539
0-9802094-7-1
OCLC:
923251603

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Library Catalog Using Articles+ Library Account